Finepoint Capital LP
- SEC CIK
- 0001608126
- Latest filing
- Aug 13, 2026
ASND holding history
Ascendis Pharma A/S in every 13F filed by Finepoint Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ASND overviewAll 13F holders of ASNDFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −179,872−100.0% | Sold out | Holders |
| Q1 2025 | 179,872 | $28.0M | 4.7% | −5,000−2.7% | Reduced | Holders |
| Q4 2024 | 184,872 | $25.5M | 2.9% | −5,200−2.7% | Reduced | Holders |
| Q3 2024 | 190,072 | $28.4M | 3.5% | +800+0.4% | Added | Holders |
| Q2 2024 | 189,272 | $25.8M | 7.3% | +13,600+7.7% | Added | Holders |
| Q1 2024 | 175,672 | $26.6M | 6.8% | +11,900+7.3% | Added | Holders |
| Q4 2023 | 163,772 | $20.6M | 7.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 163,772 | $15.3M | 7.6% | +24,000+17.2% | Added | Holders |
| Q2 2023 | 139,772 | $12.5M | 4.3% | −16,300−10.4% | Reduced | Holders |
| Q1 2023 | 156,072 | $16.7M | 6.4% | +22,036+16.4% | Added | Holders |
| Q4 2022 | 134,036 | $16.4M | 5.3% | +10,636+8.6% | Added | Holders |
| Q3 2022 | 123,400 | $12.7M | 4.2% | −36,100−22.6% | Reduced | Holders |
| Q2 2022 | 159,500 | $14.8M | 5.1% | +159,500 | New | Holders |